1. Market Research
  2. > ACE BioSciences A/S – Product Pipeline Review – 2013

ACE BioSciences A/S – Product Pipeline Review – 2013

  • May 2013
  • -
  • Global Markets Direct
  • -
  • 23 pages

ACE BioSciences A/S – Product Pipeline Review – 2013

Summary

Global Market Direct’s pharmaceuticals report, “ACE BioSciences A/S - Product Pipeline Review - 2013” provides data on the ACE BioSciences A/S’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ACE BioSciences A/S’s corporate website, SEC filings, investor presentations and featured press releases, both from ACE BioSciences A/S and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- ACE BioSciences A/S - Brief ACE BioSciences A/S overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of ACE BioSciences A/S human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of ACE BioSciences A/S with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the ACE BioSciences A/S’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate ACE BioSciences A/S’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of ACE BioSciences A/S in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the ACE BioSciences A/S’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with ACE BioSciences A/S.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of ACE BioSciences A/S and identify potential opportunities in those areas.

Table Of Contents

ACE BioSciences A/S - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
ACE BioSciences A/S Snapshot 4
ACE BioSciences A/S Overview 4
Key Information 4
Key Facts 4
ACE BioSciences A/S - Research and Development Overview 5
Key Therapeutic Areas 5
ACE BioSciences A/S - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
ACE BioSciences A/S - Pipeline Products Glance 9
ACE BioSciences A/S - Early Stage Pipeline Products 9
Pre-Clinical Products/Combination Treatment Modalities 9
ACE BioSciences A/S - Drug Profiles 10
ACE-720 10
Product Description 10
Mechanism of Action 10
RandD Progress 10
Galaczym 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
ACE BioSciences A/S - Dormant Projects 12
ACE BioSciences A/S - Locations And Subsidiaries 13
Head Office 13
Financial Deals Landscape 14
ACE BioSciences A/S, Deals Summary 14
ACE BioSciences A/S, Pharmaceuticals and Healthcare, Deal Details 15
Venture Financing 15
ACE BioSciences Raises US$17.14 Million In Venture Financing 15
Partnerships 16
ACE BioSciences Enters Into Co-Development Agreement With PATH 16
ACE BioSciences Enters Into Co-Development Agreement With PATH 18
Licensing Agreements 19
ACE BioSciences Enters Into Licensing Agreement With Cambridge BioStability 19
Acquisition 20
Zymenex Acquires ACE Biosciences 20
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23



List of Tables

ACE BioSciences A/S, Key Information 4
ACE BioSciences A/S, Key Facts 4
ACE BioSciences A/S - Pipeline by Indication, 2013 6
ACE BioSciences A/S - Pipeline by Stage of Development, 2013 7
ACE BioSciences A/S - Monotherapy Products in Pipeline, 2013 8
ACE BioSciences A/S - Pre-Clinical, 2013 9
ACE BioSciences A/S - Dormant Developmental Projects,2013 12
ACE BioSciences A/S, Deals Summary 14
ACE BioSciences Raises US$17.14 Million In Venture Financing 15
ACE BioSciences Enters Into Co-Development Agreement With PATH 16
ACE BioSciences Enters Into Co-Development Agreement With PATH 18
ACE BioSciences Enters Into Licensing Agreement With Cambridge BioStability 19
Zymenex Acquires ACE Biosciences 20



List of Figures

ACE BioSciences A/S - Pipeline by Indication, 2013 6
ACE BioSciences A/S - Pipeline by Stage of Development, 2013 7
ACE BioSciences A/S - Monotherapy Products in Pipeline, 2013 8

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.